Items where authors include "Sharrack, B"

Article

Mikolaizak, AS, Rochester, L, Maetzler, W et al. (50 more authors) (2022) Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol. PLoS ONE, 17 (10). e0269615. ISSN 1932-6203

Achini‐Gutzwiller, FR, Snowden, JA orcid.org/0000-0001-6819-3476, Corbacioglu, S et al. (78 more authors) (2022) Haematopoietic stem cell transplantation for severe autoimmune diseases in children : a review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation. British Journal of Haematology, 198 (1). pp. 24-45. ISSN 0007-1048

Mazzà, C orcid.org/0000-0002-5215-1746, Alcock, L, Aminian, K et al. (54 more authors) (2021) Technical validation of real-world monitoring of gait : a multicentric observational study. BMJ Open, 11 (12). e050785. ISSN 2044-6055

De Angelis, F, Connick, P, Parker, RA et al. (25 more authors) (2020) Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT. Efficacy and Mechanism Evaluation, 7 (3). ISSN 2050-4365

Chataway, J, De Angelis, F, Connick, P et al. (65 more authors) (2020) Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial. The Lancet Neurology, 19 (3). pp. 214-225. ISSN 1474-4422

Connick, P, De Angelis, F, Parker, RA et al. (21 more authors) (2018) Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ Open, 8 (8). 021944. ISSN 2044-6055

Marshall, I, Thrippleton, MJ, Bastin, ME et al. (16 more authors) (2018) Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study. Journal of Neurology, 265 (8). pp. 1795-1802. ISSN 0340-5354

Plug, L, Sharrack, B and Reuber, M (2011) Metaphors in the description of seizure experiences: Common expressions and differential diagnosis. Language and Cognition, 3 (2). 209 - 234. ISSN 1866-9808

Plug, L, Sharrack, B and Reuber, M (2010) Seizure, Fit or Attack? The Use of Diagnostic Labels by Patients with Epileptic or Non-epileptic Seizures. Applied Linguistics, 31 (1). 94 - 114. ISSN 0142-6001

Proceedings Paper

Doshi, A, De Angelis, F, Muhlert, N et al. (21 more authors) (2018) Multiple Sclerosis Impact Scale and brain volume are independent predictors of cognitive impairment in Secondary Progressive Multiple Sclerosis. In: European Journal of Neurology. 4th Congress of the European Academy of Neurology, 16-19 Jul 2018, Lisbon, Portugal. Wiley , pp. 69-70.

De Angelis, F, Gomez, AG, Parker, R et al. (16 more authors) (2017) Examining cross-sectional relationships of optical coherence tomography, cervical cord MRI and disability in secondary progressive MS. In: Multiple Sclerosis Journal. MS Paris 2017: 7th Joint ECTRIMS - ACTRIMS Meeting, 25-28 Oct 2017, Paris, France. SAGE Publications , pp. 275-276.

Chataway, J, Chandran, S, Miller, D et al. (7 more authors) (2016) THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MS - CURRENT UPDATE. In: Journal of Neurology, Neurosurgery and Psychiatry. ABN Annual Meeting, 17-19 May 2016, Brighton, UK. BMJ Publishing Group , e1-e1.

Chataway, J, Chandran, S, Miller, D et al. (6 more authors) (2016) RECRUITMENT IN MULTIPLE SCLEROSIS TRIALS: THE MS-SMART EXPERIENCE. In: Journal of Neurology, Neurosurgery and Psychiatry. ABN Annual Meeting, 17-19 May 2016, Brighton, UK. BMJ Publishing Group , e1-e1.